Orthofix Medical Stock Price, News & Analysis (NASDAQ:OFIX) $10.79 +0.34 (+3.25%) (As of 11:27 AM ET) Add Compare Share Share Today's Range$10.46▼$10.8850-Day Range$9.69▼$13.0752-Week Range$9.57▼$23.19Volume113,881 shsAverage Volume433,182 shsMarket Capitalization$396.61 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Orthofix Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside34.0% Upside$14.00 Price TargetShort InterestBearish9.09% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.05Based on 4 Articles This WeekInsider TradingAcquiring Shares$101,025 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($3.16) to ($1.40) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.95 out of 5 starsMedical Sector607th out of 948 stocksMedical Devices Industry12th out of 17 stocks 3.0 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $14.00, Orthofix Medical has a forecasted upside of 34.0% from its current price of $10.45.Amount of Analyst CoverageOrthofix Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.09% of the outstanding shares of Orthofix Medical have been sold short.Short Interest Ratio / Days to CoverOrthofix Medical has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Orthofix Medical has recently increased by 12.08%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OFIX. Previous Next 1.7 News and Social Media Coverage News SentimentOrthofix Medical has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Orthofix Medical this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows2 people have added Orthofix Medical to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $101,025.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.70% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow in the coming year, from ($3.16) to ($1.40) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Orthofix Medical Stock (NASDAQ:OFIX)Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.Read More OFIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OFIX Stock News HeadlinesDecember 4, 2023 | seekingalpha.comOrthofix Medical: Under New ManagementDecember 2, 2023 | markets.businessinsider.comOrthofix Medical: Hold Rating Affirmed Amid Leadership Changes and Integration ChallengesDecember 6, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.December 1, 2023 | benzinga.comSpinal Implants Market size to grow by USD 3.57 billion from 2023-2028, North America to account for 43% of market growth - TechnavioNovember 30, 2023 | americanbankingnews.comOrthofix Medical (NASDAQ:OFIX) Lowered to "Sell" at StockNews.comNovember 23, 2023 | finance.yahoo.comDoes Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect?November 22, 2023 | finance.yahoo.comUnited States Wound Biologics Market Insights 2023-2028: with Avita Medical, Organogenesis, Smith+Nephew, Vericel, and Orthofix DominatingNovember 21, 2023 | benzinga.comSHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Orthofix Medical Inc. (OFIX) for Potential Violations of Securities LawsDecember 6, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 9, 2023 | finance.yahoo.comOrthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | markets.businessinsider.comWhat Wall Street expects from Orthofix Medical's earningsNovember 6, 2023 | markets.businessinsider.comOrthofix Medical Announces Launch Of WaveForm L Lateral Lumbar Interbody System - Quick FactsNovember 6, 2023 | finance.yahoo.comOrthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion ProceduresOctober 22, 2023 | barrons.comOrthofix Medical Inc. (OFIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsOctober 21, 2023 | msn.comRoth MKM Initiates Coverage of Orthofix Medical (OFIX) with Neutral RecommendationOctober 18, 2023 | finance.yahoo.comOrthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023October 13, 2023 | msn.comOrthofix’s OsteoCove graft receives US FDA 510k clearanceOctober 13, 2023 | finance.yahoo.comOrthofix (OFIX) Soars 6.4%: Is Further Upside Left in the Stock?October 13, 2023 | theglobeandmail.comWolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc.October 12, 2023 | finance.yahoo.comOrthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic ProceduresOctober 9, 2023 | benzinga.comOrthofix Medical Investors: Company Investigated by the Portnoy Law FirmOctober 9, 2023 | benzinga.comHagens Berman Encourages Orthofix Medical (OFIX) Shareholders to Contact the FirmOctober 4, 2023 | stockhouse.comOrthofix Shareholder AlertOctober 1, 2023 | theglobeandmail.comROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation - OFIXSeptember 27, 2023 | benzinga.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation - OFIXSeptember 26, 2023 | tmcnet.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation - OFIXSeptember 26, 2023 | finance.yahoo.comImplantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - TechnavioSee More Headlines Receive OFIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2023Today12/06/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Devices Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:OFIX CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone(214) 937-2000Fax599 9 461 6978Employees1,092Year Founded1980Price Target and Rating Average Stock Price Target$14.00 High Stock Price Target$16.00 Low Stock Price Target$12.00 Potential Upside/Downside+34.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($3.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,750,000.00 Net Margins-20.39% Pretax Margin-19.99% Return on Equity-7.26% Return on Assets-5.15% Debt Debt-to-Equity Ratio0.14 Current Ratio2.58 Quick Ratio1.13 Sales & Book Value Annual Sales$668.46 million Price / Sales0.57 Cash Flow$1.77 per share Price / Cash Flow5.89 Book Value$16.71 per share Price / Book0.63Miscellaneous Outstanding Shares36,757,000Free Float35,029,000Market Cap$384.11 million OptionableOptionable Beta1.02 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Catherine M. Burzik M.A. (Age 73)Interim CEO & Chair of the Board Comp: $137.5kMs. Kimberley A. Elting (Age 58)President of Global Orthopedics Comp: $766.67kMr. Kevin J. Kenny (Age 58)President of Global Spine Business Comp: $607.64kMr. Geoffrey C. GillespieVP, Corporate Controller & Interim CFOMr. Roberto DonadelloSenior Vice President of Global OperationsDr. Frank Vizesi Ph.D.Chief Scientific OfficerMr. Dan E. YarbroughVice President of Investor RelationsMs. Jill MasonInterim Chief Ethics & Compliance Officer and VP of Corporate CounselMs. Suzanne ArmstrongChief Human Resources OfficerMr. Ehab M. Esmail (Age 51)Senior Vice President of Global Quality, Regulatory & Clinical Affairs More ExecutivesKey CompetitorsAnika TherapeuticsNASDAQ:ANIKSurmodicsNASDAQ:SRDXAccurayNASDAQ:ARAYAxoGenNASDAQ:AXGNMaxCyteNASDAQ:MXCTView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Bought 7,363 shares on 11/30/2023Ownership: 0.069%Deutsche Bank AGSold 48,815 shares on 11/24/2023Ownership: 0.046%Public Sector Pension Investment BoardSold 16,691 shares on 11/22/2023Ownership: 0.122%Graham Capital Management L.P.Bought 28,288 shares on 11/22/2023Ownership: 0.077%Comerica BankSold 250,871 shares on 11/21/2023Ownership: 0.045%View All Insider TransactionsView All Institutional Transactions OFIX Stock Analysis - Frequently Asked Questions Should I buy or sell Orthofix Medical stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares. View OFIX analyst ratings or view top-rated stocks. What is Orthofix Medical's stock price target for 2024? 3 Wall Street research analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price. View analysts price targets for OFIX or view top-rated stocks among Wall Street analysts. How have OFIX shares performed in 2023? Orthofix Medical's stock was trading at $20.53 at the beginning of the year. Since then, OFIX stock has decreased by 49.1% and is now trading at $10.45. View the best growth stocks for 2023 here. When is Orthofix Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024. View our OFIX earnings forecast. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc. (NASDAQ:OFIX) issued its earnings results on Wednesday, November, 8th. The medical device company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.75) by $0.02. The medical device company had revenue of $184.01 million for the quarter, compared to the consensus estimate of $185.50 million. Orthofix Medical had a negative net margin of 20.39% and a negative trailing twelve-month return on equity of 7.26%. What ETF holds Orthofix Medical's stock ? Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio. What is Brad Mason's approval rating as Orthofix Medical's CEO? 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR). Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Rubric Capital Management LP (9.35%), Armistice Capital LLC (8.07%), AWM Investment Company Inc. (1.63%), Assenagon Asset Management S.A. (1.55%), Emerald Advisers LLC (1.53%) and Emerald Mutual Fund Advisers Trust (1.25%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar. View institutional ownership trends. How do I buy shares of Orthofix Medical? Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:OFIX) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.